Compare Moderna, Inc. (MRNA) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Revvity Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | RVTY | |
|---|---|---|
Market Cap | $23.60B | $11.87B |
Sector | Health | Technology |
52-Week High | $81.80 | $117.75 |
52-Week Low | $22.36 | $82.26 |
Enterprise Value | $19.70B | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
